Literature DB >> 27621577

Technical advances in external radiotherapy for hepatocellular carcinoma.

Shin-Hyung Park1, Jae-Chul Kim1, Min Kyu Kang1.   

Abstract

Radiotherapy techniques have substantially improved in the last two decades. After the introduction of 3-dimensional conformal radiotherapy, radiotherapy has been increasingly used for the treatment of hepatocellular carcinoma (HCC). Currently, more advanced techniques, including intensity-modulated radiotherapy (IMRT), stereotactic ablative body radiotherapy (SABR), and charged particle therapy, are used for the treatment of HCC. IMRT can escalate the tumor dose while sparing the normal tissue even though the tumor is large or located near critical organs. SABR can deliver a very high radiation dose to small HCCs in a few fractions, leading to high local control rates of 84%-100%. Various advanced imaging modalities are used for radiotherapy planning and delivery to improve the precision of radiotherapy. These advanced techniques enable the delivery of high dose radiotherapy for early to advanced HCCs without increasing the radiation-induced toxicities. However, as there have been no effective tools for the prediction of the response to radiotherapy or recurrences within or outside the radiation field, future studies should focus on selecting the patients who will benefit from radiotherapy.

Entities:  

Keywords:  3D-conformal radiotherapy; Charged particle therapy; Hepatocellular carcinoma; Image-guided radiotherapy; Intensity-modulated radiotherapy; Radiotherapy; stereotactic ablative body radiotherapy

Mesh:

Year:  2016        PMID: 27621577      PMCID: PMC4997637          DOI: 10.3748/wjg.v22.i32.7311

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

1.  Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Ryohei Sasaki; Yuichi Hori; Yoshio Hishikawa; Yonson Ku; Masao Murakami
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

2.  The rotating biplanar linac-magnetic resonance imaging system.

Authors:  Biagio Gino Fallone
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

3.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

4.  Local radiotherapy for patients with unresectable hepatocellular carcinoma.

Authors:  Won Park; Do Hoon Lim; Seung Woon Paik; Kwang Cheol Koh; Moon Seok Choi; Cheol Keun Park; Byung Chul Yoo; Jeong Eun Lee; Min Kyu Kang; Young Je Park; Hee Rim Nam; Yong Chan Ahn; Seung Jae Huh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

5.  Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments.

Authors:  P-M Wang; W-C Hsu; N-N Chung; F-L Chang; A Fogliata; L Cozzi
Journal:  Strahlenther Onkol       Date:  2013-02-20       Impact factor: 3.621

6.  Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.

Authors:  Cynthia L Eccles; Jean-Pierre Bissonnette; Tim Craig; Mojgan Taremi; Xia Wu; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

7.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

8.  Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.

Authors:  Alyson McIntosh; Klaus D Hagspiel; Abdullah M Al-Osaimi; Patrick Northup; Stephen Caldwell; Carl Berg; J Fritz Angle; Curtis Argo; Geoffrey Weiss; Tyvin A Rich
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

9.  The impact of beam angle configuration of intensity-modulated radiotherapy in the hepatocellular carcinoma.

Authors:  Sung Hoon Kim; Min Kyu Kang; Ji Woon Yea; Sung Kyu Kim; Ji Hoon Choi; Se An Oh
Journal:  Radiat Oncol J       Date:  2012-09-30

10.  A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.

Authors:  Dong Chen; Renben Wang; Xiangjiao Meng; Tonghai Liu; Hongjiang Yan; Rui Feng; Shangang Liu; Shumei Jiang; Xiaoqing Xu; Kunli Zhu; Xue Dou
Journal:  Radiat Oncol       Date:  2014-02-06       Impact factor: 3.481

View more
  6 in total

1.  Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis.

Authors:  Xiao-Fei Zhang; Lin Lai; Hui Zhou; Yuan-Jun Mo; Xu-Quan Lu; Min Liu; Yun-Xin Lu; En-Cun Hou
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.240

2.  Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis.

Authors:  Qianqian Zhao; Kunli Zhu; Jinbo Yue; Zhonghua Qi; Shumei Jiang; Xiaoqing Xu; Rui Feng; Renben Wang
Journal:  Ther Clin Risk Manag       Date:  2016-12-22       Impact factor: 2.423

3.  The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015.

Authors:  Young-Seok Seo; Mi-Sook Kim; Jin-Kyu Kang; Won-Il Jang; Hee Jin Kim; Chul Koo Cho; Hyung Jun Yoo; Eun Kyung Paik; Yu Jin Cha; Jae Sun Yoon
Journal:  Cancer Res Treat       Date:  2017-04-25       Impact factor: 4.679

4.  A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.

Authors:  Cui-Zhen Liu; Zhi-Hua Ye; Jie Ma; Rong-Quan He; Hai-Wei Liang; Zhi-Gang Peng; Gang Chen
Journal:  Technol Cancer Res Treat       Date:  2017-04-23

5.  Autophagic cell death induced by reactive oxygen species is involved in hyperthermic sensitization to ionizing radiation in human hepatocellular carcinoma cells.

Authors:  Guang-Jin Yuan; Jun-Jian Deng; De-Dong Cao; Lei Shi; Xin Chen; Jin-Ju Lei; Xi-Ming Xu
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

Review 6.  Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma.

Authors:  Jongmoo Park; Jae Won Park; Min Kyu Kang
Journal:  Yeungnam Univ J Med       Date:  2019-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.